Monday Sep 20, 2021
Monday Sep 20, 2021

Reinfection

COVID-19 antibodies reduce reinfection risk up to six months: Study

Sep 15, 2021
A new study has found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months.
Nepal's First Online News Portal
Published by Nepalnews Pvt Ltd
Editor: Raju Silwal
Information Department Registration No. 1505 / 076-77

Contact

KMC-02, UttarDhoka,
Lazimpat, Nepal

Newsroom
+977–01–4445751 / 4445754

E-mail
info@nepalnews.com editor@nepalnews.com

Terms of Use Disclaimer
© NepalNews. 2021 All rights reserved. | Nepal's First News Portal